Douglas W. Pagan, Chief Financial Officer at Paratek Pharmaceuticals, Inc. (PRTK), sold 2,495 shares at $6.77 ($17K) on 2019-02-05, disclosed to the SEC on 2019-02-07.
Scheduled sale ($17k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2018-10-04 | $149K | — | Filing → |
| PRTK | SELL | 2018-04-10 | $133K | — | Filing → |
| PRTK | SELL | 2018-02-07 | $463K | — | Filing → |